KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Interest Coverage Ratio (2016 - 2025)

West Pharmaceutical Services' Interest Coverage Ratio history spans 17 years, with the latest figure at 783.0 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 292.48% year-over-year to 783.0; the TTM value through Dec 2025 reached 1169.8, up 515.79%, while the annual FY2025 figure was 1169.8, 515.79% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 783.0 at West Pharmaceutical Services, down from 838.0 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 1537.0 in Q2 2025 and bottomed at 783.0 in Q4 2025.
  • The 5-year median for Interest Coverage Ratio is 85.43 (2022), against an average of 156.7.
  • The largest YoY upside for Interest Coverage Ratio was 1726.86% in 2025 against a maximum downside of 292.48% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 70.77 in 2021, then increased by 7.81% to 76.29 in 2022, then soared by 75.75% to 134.08 in 2023, then tumbled by 248.79% to 199.5 in 2024, then plummeted by 292.48% to 783.0 in 2025.
  • Per Business Quant, the three most recent readings for WST's Interest Coverage Ratio are 783.0 (Q4 2025), 838.0 (Q3 2025), and 1537.0 (Q2 2025).